dsip-lab-tested DSIP Vial (5mg) | High Purity Research Peptide DSIP 5MG Research Peptide |

For patients requiring long-term Clostridium intervention during remission, attention should be paid to the cumulative risk of native gut microbiota disruption

Limited long-term human studies

The peptide counteracted picrotoxin (non-competitive GABA receptor Cl channel blocker), isoniazid (inhibitor of glutamic acid decarboxylase and GABA synthesis), and bicuculline (GABA-A antagonist), all through dose-dependent protective effects without producing behavioral changes when administered alone

It is studied through vascular marker response, VEGF related signalling, nitric oxide pathway interaction, tendon fibroblast behaviour, collagen matrix organisation and inflammatory marker changes